The number of people with susceptibility test result for rifampicin in Côte d'Ivoire
Côte d'Ivoire: The number of people with susceptibility test result for rifampicin was 8,494 in 2021. ◆ Volatile
Latest (2021)
8,494
Change on year
up 561.0%
World rank
25th
of 155 countries
All-time high
8,494
in 2021
All-time low
995
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Côte d'Ivoire, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Côte d'Ivoire stood at 8,494. That is the highest value across all 5 years on record.
The figure is up 561.0% on the previous year and up 753.7% over five years.
Côte d'Ivoire ranks 25th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Côte d'Ivoire, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 995 | — |
| 2018 | 6,932 | +596.7% |
| 2019 | 1,598 | -76.9% |
| 2020 | 1,285 | -19.6% |
| 2021 | 8,494 | +561.0% |
Côte d'Ivoire compared with similar countries
- Côte d'Ivoire's 8,494 is above the median for lower middle income countries, which is 2,804, 3.0× the median. (32 countries reporting)
- Côte d'Ivoire's 8,494 is above the median for Sub-Saharan Africa, which is 2,015, 4.2× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,175 | 995 | 6,932 | 3 |
| 2020s | 4,890 | 1,285 | 8,494 | 2 |
Countries ranked near Côte d'Ivoire
More health data for Côte d'Ivoire
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 864.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,592 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 12 (2025)
- Population ages 00-04, female, annual growth rate 1.01 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Côte d'Ivoire?
- The number of people with susceptibility test result for rifampicin in Côte d'Ivoire was 8,494 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Côte d'Ivoire?
- The highest recorded value was 8,494 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Côte d'Ivoire?
- The lowest recorded value was 995 in 2017.
- How does Côte d'Ivoire rank for the number of people with susceptibility test result for rifampicin?
- Côte d'Ivoire ranks 25th out of 155 countries with data for 2021.
- Where does this Côte d'Ivoire data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).